Even if HAT inhibitors have an essential function in tumor suppression and may exhibit a potential immunotherapeutic effect in cancer treatment, the significance of HAT inhibitors has been well-covered by the in-depth research on HDACi. The gene discussed is TMPRSS11D; the disease is cancer.